Mangaluru: 3 days after attack RSS activist loses fight for his life

Bengaluru, Jun 23: Karnataka Congress leader and Kanakapura MLA DK Shivakumar said on Monday that in the wake of coronavirus pandemic, people of his assembly constituency have taken a unanimous decision of remaining under voluntary lockdown until July 1.

The decision was taken after he headed a meeting at Kanakapura on Sunday, at the office of Kanakapura Municipality.

"Let us consider the situation after July 1, hold a similar meeting, and take the next decision. It has nothing to do with the state government's mandate. It came to the conclusion that this was a decision that we all voluntarily took," said DK Shivakumar.

DK Shivakumar informed that the merchants have agreed to sell groceries, fruits, vegetables, fennel, meat and other food items from 7 a.m. to 11 p.m. only. District authorities, DCs, SPs and hospital representatives have decided the timings of clinics and drug stores.

He further said, "In this self-motivated lockdown, unnecessary driving should be avoided. The social gap must be maintained. No one should be oppressed by anyone."

Member of Parliament DK Suresh, Ravi - Ramanagara District Collector Archana, SP Anoop Shetty, and Kanakapura Planning Authority Chairman Jagannath were also present in the meeting.

Bengaluru, Mar 27: Karnataka has so far witnessed 62 Covid-19 positive cases including 3 deaths and five discharges, according to mid-day bulletin released by the Department of Health and Family Welfare.

The state on Friday witnessed a sudden spike in the number of Covid-19 cases with the officials confirming seven new positive cases overnight (26 March 5:00 pm to 27 March 8:00 am) across the state including a 10-month-old baby boy becoming the youngest Covid-19 patient in Karnataka and second youngest patient in India after 8-month-old baby in Jammu and Kashmir.

According to mid-day bulletin released by the Department of Health and Family Welfare on Friday, Karnataka witnessed 62 Covid-19 positive cases including 3 deaths and five discharges. The 10-month-old baby (P56) even though had no travel history to any of the Covid-19 affected countries, officials revealed that the family members had taken the baby to Kerala and six primary contacts have been established and put under home quarantine.

This apart, a 20-year-old male (P57) who returned from Colombo, a 25-year-old female (P58) who returned from London have also been tested positive for Covid-19. Further, a 35-year-old female (P59) and 33-year-old female (P61) said to be the primary contacts of P25 (House Maid) have also been tested positive according to the officials

Besides, a 60-year-old male (P60) who returned to Sira in Tumakuru by train from New Delhi died on Friday morning also tested positive. His primary contacts, including health care professionals have been put under house quarantine. According to officials a 22-year-old male (P62) from Uttara Kannada with travel history to Dubai has also been tested positive for Covid 19 on Friday.

According to bulletin, all the patients barring P60 are being treated at designated isolation hospitals in Mangaluru, Bengaluru and Uttara Kannada. In the meantime, P1 and P3 from Bengaluru have been discharged from RGICD, according to officials.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.